HC Wainwright Reiterates “Buy” Rating for OKYO Pharma (NASDAQ:OKYO)

HC Wainwright reiterated their buy rating on shares of OKYO Pharma (NASDAQ:OKYO – Free Report) in a research report report published on Tuesday morning,Benzinga reports. They currently have a $7.00 target price on the stock. OKYO Pharma Stock Down 0.9 % NASDAQ OKYO opened at $1.09 on Tuesday. OKYO Pharma has a fifty-two week low […]

Leave a Reply

Your email address will not be published.

Previous post Blackrock Municipal 2030 Target Term Trust (NYSE:BTT) Short Interest Update
Next post Outlook Therapeutics’ (OTLK) Neutral Rating Reaffirmed at Chardan Capital